Inflammation linked to fatigue after radiotherapy
Patients who experience fatigue during radiotherapy for breast or prostate cancer may be reacting to activation of the proinflammatory cytokine network, a known inflammatory pathway, according to researchers from the University of California, Los Angeles.
Patients who experience fatigue during radiotherapy for breast or prostate cancer may be reacting to activation of the proinflammatory cytokine network, a known inflammatory pathway, according to researchers from the University of California, Los Angeles.
In patients with early-stage breast and prostate cancer, there was a strong connection between radiotherapy and fatigue.
Also, increases in serum markers of cytokine activity were linked with fatigue (Clin Can Res online, August 18, 2009).
Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer
A patient case of a 50-year-old man with hormone-sensitive prostate cancer sparked a debate among oncologists regarding the best course of action.
